# Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants

> **NCT05030012** · NA · TERMINATED · sponsor: **Vapotherm, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Infant, Premature
- Neonatal Respiratory Distress
- Oxygen Saturation
- Bronchopulmonary Dysplasia

## Interventions

- **DEVICE:** Automated Control
- **DEVICE:** Manual Control

## Key facts

- **NCT ID:** NCT05030012
- **Lead sponsor:** Vapotherm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-02
- **Primary completion:** 2023-10-19
- **Final completion:** 2023-10-19
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** No path to obtain FDA approval for the legacy Precision Flow OAM.
- **Last updated:** 2024-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05030012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05030012, "Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05030012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*